JSC Pharmasyntez-Nord

Importer · Russia

Pharmaceutical Manufacturing – Oncology, Endocrinology, Autoimmune, and Biotech Drugs

About JSC Pharmasyntez-Nord

Founded in 2011, JSC Pharmasyntez-Nord is a Russian pharmaceutical company specializing in the development and production of innovative drugs for oncology, autoimmune diseases, and diabetes mellitus. The company manufactures over 45 trade names of antineoplastic drugs, with 99% included in the List of Vital and Essential Drugs of the Russian Ministry of Health. In 2023, it began producing Russia's first recombinant long-acting human insulin analog. Pharmasyntez-Nord operates under GMP standards, featuring advanced production lines for tablets, capsules, vials, prefilled syringes, and lyophilized products.